Image

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Study compares Lutetium treatment to observation in PSMA-positive prostate cancer.

Recruiting
18 years and older
Male
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is exploring a treatment called lutetium (177Lu) vipivotide tetraxetan for men with a type of prostate cancer that has spread to a few spots, called oligometastatic prostate cancer (OMPC). The study aims to see if this treatment can slow down the cancer's growth and delay the need for other treatments like androgen deprivation therapy (ADT), which lowers male hormones. Participants will undergo scans to check the cancer's spread and receive radiation called stereotactic body radiation therapy (SBRT)

  • The study will last about 6.5 years, including treatments and follow-ups.
  • Participants will have frequent visits, especially during the first four cycles of treatment.
  • Only men whose prostate cancer has returned after initial treatment and have specific cancer characteristics can join.

Participants should consider the lengthy commitment and frequent visits. They should also be aware of the specific eligibility criteria, including previous treatments and cancer stage requirements. The study aims to improve quality of life by delaying more aggressive treatments.

Print
Study details
    Oligometastatic Prostate Cancer (OMPC)

NCT05939414

Novartis Pharmaceuticals

21 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.